Sommario
L’incidenza del Diabete Mellito (DM) è in continuo aumento. Nonostante le nuove tecnologie abbiano contribuito a cambiare la qualità e la prospettiva di vita dei pazienti, ad oggi gli unici trattamenti in grado di normalizzare i livelli di glicemia senza terapia insulinica esogena a lungo termine sono il trapianto di pancreas e il trapianto di isole pancreatiche. In questo documento descriviamo brevemente le varie tipologie di trapianto di pancreas e le indicazioni per i pazienti con DM tipo 1 e tipo 2.
Bibliografia
International Diabetes Federation (2021) IDF diabetes atlas, 10th edn. IDF, Brussels
Osservatorio ARNO Diabete (2019) Il profilo assistenziale della popolazione con diabete. Rapporto 2019. Collana Rapporti ARNO, 31:55
Pala L, Dicembrini I, Mannucci E (2019) Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Acta Diabetol 56(9):973–980
Holt RI, DeVries JH, Hess-Fischl A et al. (2021) The management of type 1 diabetes in adults. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care 44(11):2589–2625
Orlando G, Stratta RJ, Light J (2011) Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant 16(1):110–115
Alhamad T, Kunjal R, Wellen J et al. (2020) Three-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation in type 2 diabetes patients. Am J Transplant 20(3):788–796
Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC (1967) Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61(6):827–837
Boggi U, Vistoli F, Marchetti P et al. (for the World Consensus Group on Pancreas Transplantation) (2021) First world consensus conference on pancreas transplantation: Part I – methods and results of literature search. Am J Transplant 21(S3):1–16
Boggi U, Vistoli F, Andres A et al. (2021) First World Consensus Conference on pancreas transplantation: Part II – recommendations. Am J Transplant 21(S3):17–59
Kandaswamy R, Stock PG, Gustafson SK et al. (2020) OPTN/SRTR 2018 annual data report: pancreas. Am J Transplant 20(S1):131–192
Dean PG, Kukla A, Stegall MD, Kudva YC (2017) Pancreas transplantation. BMJ (Online) 357:1–11
Grochowiecki T, Szmidt J, Gałazka Z et al. (2006) Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients. Transplant Proc 38(1):261–262
Robertson P, Davis C, Larsen J et al. (for the American Diabetes Association) (2004) Pancreas transplantation in type 1 diabetes. Diabetes Care 27(S1):105
Sucher R, Rademacher S, Jahn N et al. (2019) Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases. BMC Nephrol 20(1):1–10
Mangus RS, Powelson J, Kinsella SB et al. (2013) Pretransplant coronary artery disease associated with worse clinical outcomes in pancreas transplantation. Clin Transplant 27(4):442–447
Humar A, Ramcharan T, Kandaswamy R et al. (2004) Technical failures after pancreas transplants: why grafts fail and the risk factors – a multivariate analysis. Transplantation 78(8):1188–1192
Shapiro AM, Pokrywczynska M, Ricordi C (2017) Clinical pancreatic islet transplantation. Nat Rev Endocrinol 13(5):268–277
CITR Coordinating Center (2015) Scientific summary of the Collaborative Islet Transplant Registry (CITR) 2015. Tenth Annual Report: background and purpose 2015:1–16
Hering BJ et al. (2016) Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39(7):1230–1240
Ames AM, Lakey JR, Ryan EA et al. (2009) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343(4):230–238
Maffi P, Scavini M, Socci C et al. (2011) Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. Rev Diabet Stud 8(1):44–50
Maffi P, Secchi A (2019) Islet transplantation alone versus solitary pancreas transplantation: an outcome-driven choice? Curr Diabetes Rep 19(5):26
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Maria Ausilia Giusti, Davide Cintorino, Calogero Antonio Ricotta, Chiara Caccamo, Paola Salis, Salvatore Gruttadauria e Alessandro Mattina dichiarano di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Additional information
Proposto da L. Sciacca.
Nota della casa editrice
Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.
Informazioni Supplementari
Rights and permissions
About this article
Cite this article
Giusti, M.A., Cintorino, D., Ricotta, C.A. et al. La sostituzione delle beta-cellule: indicazioni al trapianto di pancreas nel diabete. L'Endocrinologo 23, 399–404 (2022). https://doi.org/10.1007/s40619-022-01125-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-022-01125-1